Abstract:Objective: To investigate the role of exogenous cannabinoid HU210 in anxiety and depression-like behaviors induced by chronic neuropathic pain in mice and the effects on spontaneous firing of ventrolateral orbital (VLO) pyramidal neurons. Methods: A neuropathic pain model was established by ligation of common peroneal nerve (CPN) and allodynia was measured with Von Frey filaments. Anxiety- and depression-like behaviors were assessed by elevated plus maze and forced swimming test. The change of the spontaneous firing of pyramidal neurons in VLO was observed by extracellular recording in vivo. Results: CPN ligation mice showed a significant reduction of 50% paw withdrawal threshold (50% PWT) from day 7 to day 35. On the 13th day after CPN ligation, mice in the CPN group spent significantly less time and frequency in the open arms in the elevated plus maze and more immobility time in the forced swimming test. Intraperitoneal injection of 20 μg/kg HU210 or microinjection of 200 ng HU210 in the VLO on the 13th day after CPN ligation, mice spent significantly more time and frequency in the open arms in the elevated plus maze and less immobility time in the forced swimming test. The spontaneous firing rate of VLO pyramidal neurons reduced significantly after CPN ligation on day 13, which could be increased by intraperitoneal injection of 20 μg/kg HU210. Conclusion: Exogenous cannabinoid HU210 attenuates anxiety and depression-like behaviors induced by chronic neuropathic pain in mice, which may be related to the alternation of spontaneous firing rate of pyramidal neurons in VLO.